Myhep All is a prescription medication used to treat chronic hepatitis C viral infections. It is a combination of two antiviral drugs, velpatasvir and sofosbuvir, that work together to prevent the replication of the hepatitis C virus in the body.
Myhep All contains two active ingredients: velpatasvir and sofosbuvir. Each tablet of Myhep All contains Velpatasvir 100 mg and Sofosbuvir 400 mg.
Myhep All is used to treat chronic hepatitis C viral infections in adults. It may be prescribed for patients with or without liver cirrhosis. Myhep All can help to prevent the progression of the disease and may lead to a sustained virological response (SVR), which means that the virus is no longer detectable in the patient’s blood.
How to use Myhep All:
Myhep All should be taken as prescribed by your doctor. The tablets should be swallowed whole and not crushed or chewed. It is important to take Myhep All with food, as this can improve the absorption of the drugs. It is important to take Myhep All consistently at the same time each day to maintain the effectiveness of the medication.
The recommended dose of Myhep All is one tablet once a day. The duration of treatment can vary depending on the patient’s individual circumstances, such as the extent of liver damage and the patient’s response to the medication. The treatment duration is usually between 12 to 24 weeks. Your doctor will determine the appropriate dosage and duration of treatment for you.
Myhep All should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Mechanism of Action:
Velpatasvir and sofosbuvir work together to prevent the replication of the hepatitis C virus in the body. Velpatasvir works by inhibiting the action of a protein that the virus uses to reproduce, while sofosbuvir works by inhibiting the action of the virus’s RNA polymerase, which is required for viral replication.
Myhep All should not be taken by pregnant or breastfeeding women, as it may harm the developing fetus or nursing infant. It may also cause serious side effects in patients with liver or kidney disease. Patients who are allergic to velpatasvir or sofosbuvir should not take Myhep All.
Myhep All is contraindicated for patients with severe liver or kidney disease. It should also be avoided in patients who are allergic to velpatasvir or sofosbuvir.
Myhep All may interact with other medications, especially those that affect the liver, such as rifampin, carbamazepine, and phenytoin. It may also interact with drugs that affect heart rate, such as amiodarone. Always inform your doctor of any medications you are taking before starting treatment with Myhep All.
In the event of an overdose, contact your doctor or seek emergency medical attention immediately. Symptoms of overdose may include confusion, dizziness, and nausea.
Common side effects of Myhep All include headache, fatigue, diarrhea, and nausea. Serious side effects may include liver damage, kidney problems, and signs of an allergic reaction. If you experience any unusual symptoms while taking Myhep All, seek medical attention immediately.